{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:38:09Z","timestamp":1793216289776,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"crossref","award":["Grant Health-F3-2011-278348"],"award-info":[{"award-number":["Grant Health-F3-2011-278348"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colistin-carbapenem combination therapy is frequently used for carbapenem-resistant Gram-negative infections, but its impact on subsequent acquisition of carbapenem-resistant Enterobacterales (CRE) requires further investigation. We evaluated the incidence of CRE acquisition and performed molecular characterization of recovered isolates following treatment with colistin\u2013meropenem versus colistin monotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This analysis addressed a pre-specified secondary aim of the AIDA multicenter randomized controlled trial, which compared colistin monotherapy to colistin\u2013meropenem combination therapy for carbapenem-resistant Gram-negative infections at six hospitals in Israel, Greece, and Italy. Rectal swabs were obtained at enrollment and weekly until day 28 or discharge. Swabs were processed centrally by plating onto MacConkey agar supplemented with imipenem to selectively isolate CRE. Recovered colonies were identified using MALDI-TOF mass spectrometry, and meropenem minimum inhibitory concentrations (MICs) were determined by broth microdilution. Clinical cultures were obtained as indicated and processed locally, and CRE isolates were sent to the central laboratory for confirmation and characterization. Whole-genome sequencing was used to determine sequence types and resistance genes. Patients were excluded if they had CRE detected at baseline, either by rectal culture or as the index clinical isolate, or if no follow-up rectal cultures were available.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 197 eligible patients (99 colistin; 98 colistin\u2013meropenem), CRE acquisition occurred in 6 (3.0%): 1\/99 (1.0%, 95% CI 0.03\u20135.5%) in the monotherapy arm and 5\/98 (5.1%, 95% CI 1.7\u201311.5%) in the combination arm (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.12). Two patients in the combination arm developed clinical infections caused by CRE (bacteremia and pneumonia); none occurred in the monotherapy arm. Carbapenemase genes were detected in four of the six acquired CRE isolates: one in the monotherapy arm (\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>VIM<\/jats:sub>\n                      ) and three in the combination arm (all\n                      <jats:italic>bla<\/jats:italic>\n                      <jats:sub>KPC<\/jats:sub>\n                      ). Identified species included\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      and\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      belonging to established and emerging high-risk, multidrug-resistant clones.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients treated with colistin-meropenem had a higher, though not statistically significant, rate of CRE acquisition. Early detection of high-risk CRE clones highlights the need to weigh potential unintended consequences when selecting combination regimens for multidrug-resistant infections.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>AIDA trial was registered with\u00a0ClinicalTrials.gov, number\u00a0NCT01732250 (submitted 19-11-2012).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-025-01651-1","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:33:47Z","timestamp":1762346027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial"],"prefix":"10.1186","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct01732250","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Amir","family":"Nutman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Temkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Lellouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maayan","family":"Amar Ben Dalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mor","family":"Lurie-Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Dishon Benattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Neuberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vered","family":"Daitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Eliakim-Raz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Durante-Mangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Iossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Daikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Skiada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Pavleas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Theuretzbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Carmeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"AIDA Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Dishon Benattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaakov","family":"Dickstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Bitterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Zayyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidi","family":"Koppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Zak-Doron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Altunin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Andria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Neuberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neta","family":"Petersiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Raines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Karban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna","family":"Yahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Eliakim-Raz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Zusman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyam","family":"Atamna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vered","family":"Daitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Babich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Carmeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Nutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbar","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Daikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Skiada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Pavleas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Antoniadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigoni","family":"Kotsaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Durante-Mangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Andini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Iossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusi","family":"Cavezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Bertolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giuffre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giurazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Cuccurullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Galdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Murino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Cristinziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Corcione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Zampino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Clara Pafundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Mouton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Kristoffersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Theuretzbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"1651_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","volume":"8","author":"D van Duin","year":"2017","unstructured":"van Duin D, Doi Y. The global epidemiology of carbapenemase-producing enterobacteriaceae. Virulence. 2017;8:460\u20139. https:\/\/doi.org\/10.1080\/21505594.2016.1222343.","journal-title":"Virulence"},{"key":"1651_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cmi.2016.09.003","volume":"23","author":"SM Bartsch","year":"2017","unstructured":"Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, et al. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect. 2017;23:48. https:\/\/doi.org\/10.1016\/j.cmi.2016.09.003.","journal-title":"Clin Microbiol Infect"},{"key":"1651_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1586\/14787210.2016.1106940","volume":"14","author":"KE Goodman","year":"2016","unstructured":"Goodman KE, Simner PJ, Tamma PD, Milstone AM. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE). Expert Rev Anti-Infect Ther. 2016;14:95\u2013108. https:\/\/doi.org\/10.1586\/14787210.2016.1106940.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"1651_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1086\/671270","volume":"34","author":"M Swaminathan","year":"2013","unstructured":"Swaminathan M, Sharma S, Blash SP, Patel G, Banach DB, Phillips M, et al. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity. Infect Control Hosp Epidemiol. 2013;34:809\u201317. https:\/\/doi.org\/10.1086\/671270.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1651_CR5","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa299","author":"R Bouganim","year":"2020","unstructured":"Bouganim R, Dykman L, Fakeh O, Motro Y, Oren R, Daniel C, et al. The clinical and molecular epidemiology of noncarbapenemase-producing carbapenem-resistant Enterobacteriaceae: a case-case-control matched analysis. Open Forum Infect Dis. 2020. https:\/\/doi.org\/10.1093\/ofid\/ofaa299.","journal-title":"Open Forum Infect Dis"},{"key":"1651_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1017\/s0195941700006603","volume":"17","author":"MJM Bonten","year":"1996","unstructured":"Bonten MJM, Weinstein RA. The role of colonization in the pathogenesis of nosocomial infections. Infect Control Hosp Epidemiol. 1996;17:193\u2013200. https:\/\/doi.org\/10.1017\/s0195941700006603.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1651_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ajic.2015.12.005","volume":"44","author":"J Tischendorf","year":"2016","unstructured":"Tischendorf J, De Avila RA, Safdar N. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: a systematic review. Am J Infect Control. 2016;44:539\u201343. https:\/\/doi.org\/10.1016\/j.ajic.2015.12.005.","journal-title":"Am J Infect Control"},{"key":"1651_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/cid\/ciae110","volume":"79","author":"E Temkin","year":"2024","unstructured":"Temkin E, Solter E, Lugassy C, Chen D, Cohen A, Schwaber MJ, et al. The natural history of carbapenemase-producing Enterobacterales: progression from carriage of various carbapenemases to bloodstream infection. Clin Infect Dis. 2024;79:22\u20139. https:\/\/doi.org\/10.1093\/cid\/ciae110.","journal-title":"Clin Infect Dis an Off Publ Infect Dis Soc Am"},{"key":"1651_CR9","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1128\/AAC.01230-13","volume":"57","author":"O Zusman","year":"2013","unstructured":"Zusman O, Avni T, Leibovici L, Adler A, Friberg L, Stergiopoulou T, et al. Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems. Antimicrob Agents Chemother. 2013;57:5104\u201311. https:\/\/doi.org\/10.1128\/AAC.01230-13.","journal-title":"Antimicrob Agents Chemother"},{"key":"1651_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12866-023-03039-w","volume":"23","author":"G Bayatinejad","year":"2023","unstructured":"Bayatinejad G, Salehi M, Beigverdi R, Halimi S, Emaneini M, Jabalameli F. In vitro antibiotic combinations of Colistin, Meropenem, Amikacin, and Amoxicillin\/clavulanate against multidrug-resistant Klebsiella pneumonia isolated from patients with ventilator-associated pneumonia. BMC Microbiol. 2023;23:298. https:\/\/doi.org\/10.1186\/s12866-023-03039-w.","journal-title":"BMC Microbiol"},{"key":"1651_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1473-3099(18)30099-9","volume":"18","author":"M Paul","year":"2018","unstructured":"Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, et al. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant gram-negative bacteria: an open-label, randomised controlled trial. Lancet Infect Dis. 2018;18:391\u2013400. https:\/\/doi.org\/10.1016\/S1473-3099(18)30099-9.","journal-title":"Lancet Infect Dis"},{"key":"1651_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.03.035","author":"A Nutman","year":"2020","unstructured":"Nutman A, Lellouche J, Temkin E, Daikos G, Skiada A, Durante-Mangoni E, et al. Colistin plus meropenem for carbapenem-resistant gram-negative infections: in vitro synergism is not associated with better clinical outcomes. Clin Microbiol Infect. 2020. https:\/\/doi.org\/10.1016\/j.cmi.2020.03.035.","journal-title":"Clin Microbiol Infect"},{"key":"1651_CR13","doi-asserted-by":"publisher","DOI":"10.1056\/evidoa2200131","author":"KS Kaye","year":"2023","unstructured":"Kaye KS, Marchaim D, Thamlikitkul V, Carmeli Y, Chiu C-H, Daikos G, et al. Colistin monotherapy versus combination therapy for carbapenem-resistant organisms. NEJM Evid. 2023. https:\/\/doi.org\/10.1056\/evidoa2200131.","journal-title":"NEJM Evid"},{"key":"1651_CR14","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cmi.2021.02.002","volume":"27","author":"T Hoffman","year":"2021","unstructured":"Hoffman T, Lellouche J, Nutman A, Temkin E, Frenk S, Harbarth S, et al. The effect of prophylaxis with ertapenem versus cefuroxime\/metronidazole on intestinal carriage of carbapenem-resistant or third-generation-cephalosporin-resistant Enterobacterales after colorectal surgery. Clin Microbiol Infect. 2021;27:1481\u20137. https:\/\/doi.org\/10.1016\/j.cmi.2021.02.002.","journal-title":"Clin Microbiol Infect"},{"key":"1651_CR15","unstructured":"National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of healthcare quality promotion. Facility guidance for control of Carbapenem-resistant Enterobacteriaceae (CRE)\u202f: November 2015 update - CRE toolkit 2015. https:\/\/stacks.cdc.gov\/view\/cdc\/79104."},{"key":"1651_CR16","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. 35th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2025."},{"key":"1651_CR17","unstructured":"U.S. Food & Drug Administration. FDA-recognized antimicrobial susceptibility test interpretive criteria 2025. https:\/\/www.fda.gov\/drugs\/development-resources\/fda-recognized-antimicrobial-susceptibility-test-interpretive-criteria."},{"key":"1651_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmi.2023.01.005","volume":"29","author":"N Hassoun-Kheir","year":"2023","unstructured":"Hassoun-Kheir N, Hussein K, Karram M, Saffuri M, Badaan S, Peleg S, et al. Risk factors for acquisition of carbapenemase-producing versus non-carbapenemase-producing enterobacterales: a case-control study. Clin Microbiol Infect. 2023;29:629\u201334. https:\/\/doi.org\/10.1016\/j.cmi.2023.01.005.","journal-title":"Clin Microbiol Infect"},{"key":"1651_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00845-19","author":"K Marimuthu","year":"2019","unstructured":"Marimuthu K, Ng OT, Cherng BPZ, Fong RKC, Pada SK, De PP, et al. Antecedent carbapenem exposure as a risk factor for non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae and carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother. 2019. https:\/\/doi.org\/10.1128\/AAC.00845-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"1651_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2025.04.006","author":"H Dallasheh","year":"2025","unstructured":"Dallasheh H, Paul M. Carbapenem-resistant Enterobacterales acquisition following piperacillin-tazobactam versus carbapenem treatment: a propensity-matched cohort study. Clin Microbiol Infect. 2025. https:\/\/doi.org\/10.1016\/j.cmi.2025.04.006.","journal-title":"Clin Microbiol Infect"},{"key":"1651_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00783-20","author":"M Masego","year":"2020","unstructured":"Masego M, Marylucy MN, Mn E, John OS. Emerging transcriptional and genomic mechanisms mediating carbapenem and polymyxin resistance in enterobacteriaceae: a systematic review of current reports. MSystems. 2020. https:\/\/doi.org\/10.1128\/msystems.00783-20.","journal-title":"MSystems"},{"key":"1651_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11030421","author":"C Aurilio","year":"2022","unstructured":"Aurilio C, Sansone P, Barbarisi M, Pota V, Giaccari LG, Coppolino F, et al. Mechanisms of action of carbapenem resistance. Antibiotics. 2022. https:\/\/doi.org\/10.3390\/antibiotics11030421.","journal-title":"Antibiotics"},{"key":"1651_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00595","volume":"6","author":"X Wang","year":"2015","unstructured":"Wang X, Chen G, Wu X, Wang L, Cai J, Chan EW, et al. Increased prevalence of carbapenem resistant Enterobacteriaceae in hospital setting due to cross-species transmission of the bla NDM-1 element and clonal spread of progenitor resistant strains. Front Microbiol. 2015;6:595. https:\/\/doi.org\/10.3389\/fmicb.2015.00595.","journal-title":"Front Microbiol"},{"key":"1651_CR24","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1093\/cid\/ciad263","volume":"77","author":"MC Salom\u00e3o","year":"2023","unstructured":"Salom\u00e3o MC, Freire MP, L\u00e1zari CS, Cury AP, Rossi F, Segurado AAC, et al. Transmission of carbapenem-resistant Enterobacterales in an overcrowded emergency department: controlling the spread to the hospital. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2023;77:S46-52. https:\/\/doi.org\/10.1093\/cid\/ciad263.","journal-title":"Clin Infect Dis an Off Publ Infect Dis Soc Am"},{"key":"1651_CR25","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3201\/eid2606.191517","volume":"26","author":"R Bonnin","year":"2020","unstructured":"Bonnin R, Jousset A, Chiarelli A, Emeraud C, Glaser P, Naas T, et al. Emergence of new non-clonal group 258 high-risk clones among Klebsiella pneumoniae carbapenemase-producing K pneumoniae Isolates, France. Emerg Infect Dis J. 2020;26:1212. https:\/\/doi.org\/10.3201\/eid2606.191517.","journal-title":"Emerg Infect Dis J."},{"key":"1651_CR26","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.3389\/fmicb.2018.03198","volume":"9","author":"RL Ferreira","year":"2019","unstructured":"Ferreira RL, da Silva BCM, Rezende GS, Nakamura-Silva R, Pitondo-Silva A, Campanini EB, et al. High Prevalence of multidrug-resistant Klebsiella pneumoniae Harboring several virulence and \u03b2-lactamase encoding genes in a Brazilian intensive care unit. Front Microbiol. 2019;9:3198.","journal-title":"Front Microbiol"},{"key":"1651_CR27","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1038\/s41467-023-40872-z","volume":"14","author":"AYG Yip","year":"2023","unstructured":"Yip AYG, King OG, Omelchenko O, Kurkimat S, Horrocks V, Mostyn P, et al. Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites. Nat Commun. 2023;14:5094. https:\/\/doi.org\/10.1038\/s41467-023-40872-z.","journal-title":"Nat Commun"},{"key":"1651_CR28","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/cid\/cit795","volume":"58","author":"MJ Schwaber","year":"2014","unstructured":"Schwaber MJ, Carmeli Y. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. Clin Infect Dis. 2014;58:697\u2013703. https:\/\/doi.org\/10.1093\/cid\/cit795.","journal-title":"Clin Infect Dis"},{"key":"1651_CR29","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/cid\/ciy752","volume":"68","author":"S Tomczyk","year":"2019","unstructured":"Tomczyk S, Zanichelli V, Grayson ML, Twyman A, Abbas M, Pires D, et al. Control of carbapenem-resistant enterobacteriaceae, acinetobacter baumannii, and pseudomonas aeruginosa in healthcare facilities: a systematic review and reanalysis of quasi-experimental studies. Clin Infect Dis. 2019;68:873\u201384. https:\/\/doi.org\/10.1093\/cid\/ciy752.","journal-title":"Clin Infect Dis"},{"key":"1651_CR30","unstructured":"Word Health Organization. Guidelines for the prevention and control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in Health Care Facilities. vol. 91. 2017."},{"key":"1651_CR31","doi-asserted-by":"publisher","first-page":"15803","DOI":"10.1038\/s41598-023-42511-5","volume":"13","author":"F Durazzi","year":"2023","unstructured":"Durazzi F, Pezzani MD, Arieti F, Simonetti O, Canziani LM, Carrara E, et al. Modelling antimicrobial resistance transmission to guide personalized antimicrobial stewardship interventions and infection control policies in healthcare setting: a pilot study. Sci Rep. 2023;13:15803. https:\/\/doi.org\/10.1038\/s41598-023-42511-5.","journal-title":"Sci Rep"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01651-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-025-01651-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-025-01651-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:33:49Z","timestamp":1762346029000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-025-01651-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1651"],"URL":"https:\/\/doi.org\/10.1186\/s13756-025-01651-1","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was approved by the ethics committees of the participating hospitals and informed consent was required for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Y.C. has received grants and personal fees from MSD, Pfizer, Roche, Qpex Pharmaceuticals, and Spero Therapeutics. E.D.M. has received grants and personal fees from Advanz Pharma, Roche, Genentech, Pfizer, Shionogi, Angelini and Abbvie. G.L.D. has received grants and personal fees from Pfizer and MSD. All other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}